Companies: 10,795·Total market cap: $144.5T
Evolus, Inc.

Evolus, Inc.

EOLSNASDAQHealthcare● Active
$6.68
+$0.01(+0.18%)
Market Cap$440048032
P/E Ratio
52W High$10.62
52W Low$3.86

Evolus, Inc. (EOLS) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

eols · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
11
Hold
2
Sell
0
Strong Sell
0
Total: 13 · Buy rate: 84.6%

12-Month Price Target

High

$17.00

Consensus

$15.00

+124.4% upside

Low

$13.00

Median: $15 · Last Close: $6.68

The Evolus, Inc. (EOLS) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month EOLS price target is $15.00, representing +124.4% upside from the current price of $6.68.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $15 (124.4%)

Consensus Target

$15.00

124.4% upside

High Target

$17

154.3%

Low Target

$13

94.5%

Current Price

$6.68

as of today

Based on analyst price targets, the EOLS stock price prediction for the next 12 months ranges from $13 to $17. The consensus EOLS price forecast of $15.00 implies 124.4% upside from the current price of $6.68.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$6.670.22%

1-day model range: $6.62–$6.72. Peak: $6.72 (-0.22%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$5-27.7%
2028$4-38.7%
2029$4-43.8%
2030$4-46.4%
2031-47.7%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)52.2Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · EOLS · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$6.43BUY
MA 10$6.42BUY
MA 20$6.45BUY
MA 50$5.52BUY
MA 100$5.12BUY
MA 200$5.94BUY
Current $EOLS · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$6.54BUY
EMA 10$6.47BUY
EMA 20$6.32BUY
EMA 50$5.84BUY
EMA 100$5.70BUY
EMA 200$6.37BUY
Current $EOLS · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
BTIG2026-03-04
Maintains
BuyBuy
HC Wainwright & Co.2026-02-03
Maintains
BuyBuy
BTIG2026-01-22
Maintains
BuyBuy
Stifel2026-01-13
Maintains
BuyBuy
HC Wainwright & Co.2026-01-09
Maintains
BuyBuy
Needham2025-12-24
Maintains
HoldHold
Mizuho2025-12-02
Maintains
OutperformOutperform
BTIG2025-09-08
Maintains
BuyBuy
BTIG2025-08-06
Maintains
BuyBuy
HC Wainwright & Co.2025-08-06
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Evolus, Inc. (EOLS) stock. Of the recent 80 rating actions, 5 were upgrades and 3 were downgrades. 13 analysts currently cover EOLS.

Analyst Recommendation Trends

Buy ratings211
Hold ratings101
Sell ratings00

EOLS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$330M

↓ 28.0% YoY

Revenue Next Year

$388M

↑ 17.3% YoY

EPS This Year

$-0.09

EPS Next Year

$0.27

↓ 412.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast EOLS EPS of $-0.09 for the current fiscal year, based on estimates from 4 analysts. The EOLS revenue forecast is $330M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The EOLS stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EOLS price target is $15.00 (+124.4% upside), with an analyst consensus of Buy.

The EOLS short-term stock prediction for tomorrow is $6.67 (-0.22%). The EOLS stock price prediction for 2027 estimates an average of $5. The EOLS stock prediction for 2030 projects a range of $3–$4.

Evolus, Inc. trades on NASDAQ under the ticker EOLS. The EOLS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 85% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

EOLS forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month EOLS price target is $15.00, with a high forecast of $17.00 and a low of $13.00. The median price target is shown in the chart above when available. This implies +124.4% potential upside from the current price of $6.68.

EOLS price targetWhat is EOLS price targetEOLS analyst price targetEOLS 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.